IRONWOOD PHARMACEUTICALS INC 8-K

What Happened
On January 2, 2026, Ironwood Pharmaceuticals, Inc. filed a Current Report on Form 8‑K (Item 2.02) furnishing a press release that provides an update on its recent business activities. The press release is attached to the filing as Exhibit 99.1 and is incorporated by reference into the 8‑K.

Key Details

• Filing date: January 2, 2026 (Form 8‑K).
• Item reported: 2.02 — Results of Operations and Financial Condition (the company furnished a press release).
• Exhibit included: 99.1 — Ironwood Pharmaceuticals press release dated January 2, 2026.
• Cover page: Inline XBRL cover page of the 8‑K is furnished as Exhibit 104.

Why It Matters
This filing notifies investors that Ironwood has publicly released updated information about its business; Item 2.02 relates to results of operations and financial condition (e.g., earnings or revenue updates). Investors should read the attached press release (Exhibit 99.1) for specific operational or financial details and monitor subsequent SEC filings for any formal financial statements or disclosures that could affect the company’s outlook.